TELECOVID: COVID-19 e Telepsychotherapy: Which Variables Affect Therapeutic Experience?

• Sponsor: Istituto Auxologico Italiano (Other)
• Overall Status: Completed
• CT.gov ID: NCT05743348
• Collaborator: (none)
• Enrollment: 71
• Location: 1
• Actual Duration (Months): 12.8
• Patients Per Site Per Month: 5.5

Study Details

Study Description

Brief Summary

COVID-19 pandemic forced a widespread adoption of telemedicine, including telepsychotherapy.

Telepsychotherapy has been proven to be effective before COVID-19 breakout (Poletti et al., 2020); however, both patients and therapists were skeptical about this modality.

The aim of this study is to probe the experience of telepsychotherapy in both patients and therapists, during the COVID-19 lockdown. Thus, when the adoption of online colloquia was mandatory and not an option.

Crucially, studying the experience of telepsychotherapy during the COVID-19 pandemic allows

1. investigating also the experience of those patients and therapists that were not favorable to this kind of intervention and ii) comparing the experience of therapy in the online and face-to-face modality, in the same patients and therapists. Furthermore, we collect several psychological variables that possibly influence the experience and efficacy of telepsychotherapy (e.g., personality traits, attachment state of mind, previous traumatic experiences) to define the psychological profile behind a favorable or negative experience of telemedicine in both patients and therapists. As crucial novelty, this information is collected in both patients and their therapists, allowing the direct comparisons between the experience of the therapeutic relationship (e.g., empathy, alliance) from two different point of views.

The results of the present study may help in the definition of possible subgroups of patients who may be sufficiently responsive to telepsychotherapy and those who may benefit - exclusively - of face-to-face interventions.

Condition or Disease	Intervention/Treatment	Phase
Telepsychotherapy	Behavioral: Telepsychotherapy

Study Design

• Study Type: Observational
• Actual Enrollment: 71 participants
• Observational Model: Cohort
• Time Perspective: Cross-Sectional
• Official Title: COVID-19 e Telepsychotherapy: Which Variables Affect Therapeutic Experience?
• Actual Study Start Date: Apr 5, 2021
• Actual Primary Completion Date: Apr 30, 2022
• Actual Study Completion Date: Apr 30, 2022

Outcome Measures

Primary Outcome Measures

1. Telepsychotherapy perception [At enrollment]

   Psychometric measures of general perception/experience on the remotely delivered psychotherapy as far as efficacy and interpersonal factors are concerned

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 100 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Licensed and currently practicing psychotherapists

• Individuals currently undergoing a psychotherapy

Exclusion Criteria:

• not applicable

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Istituto Auxologico Italiano	Milan		Italy	20149

Sponsors and Collaborators

• Istituto Auxologico Italiano

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Istituto Auxologico Italiano
• ClinicalTrials.gov Identifier: NCT05743348
• Other Study ID Numbers: 23C123
• First Posted: Feb 24, 2023
• Last Update Posted: Feb 24, 2023
• Last Verified: Feb 1, 2023

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of Feb 24, 2023